Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720980 · ClinicalTrials.gov registry record
Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 6
- Enrollment target
NCT00720980 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 6 participants.
The verdict
NCT00720980 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
Granuloma annulare is a benign, usually self-limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh-colored or red papules, frequently arranged in an annular pattern on the distal extremities. Although localized granuloma annulare is most commonly observed, a generalized or disseminated form can occur. The etiology of granuloma annulare is unknown, however, multiple inciting factors have been proposed. The purpose of the investigators is to review the outcomes of treatment of granuloma annulare (GA) resistant to standard regimens that resolved after a 3-months treatment course of monthly rifampin, ofloxacin, and minocycline (ROM) therapy, successfully used to treat paucibacillary leprosy, a disease with clinical and histopathologic similarity to GA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00720980
The ClinicalTrials.gov registry entry for NCT00720980 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00720980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00720980 about?
NCT00720980 is a clinical study titled "Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy". Granuloma annulare is a benign, usually self-limiting, cutaneous dermatosis, which typically presents as asymptomatic, flesh-colored or red papules, frequently arranged in an annular pattern on the distal extremities. Although localized granuloma annulare is most commonly observed, a generalized or ...
What is the current status of trial NCT00720980?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2008-05. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00720980?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.